WEBVTT
Kind: captions
Language: en

00:00:00.030 --> 00:00:02.480 

at<00:00:00.210> this<00:00:00.390> time<00:00:00.659> minoxidil<00:00:01.620> is<00:00:01.829> the<00:00:01.979> only

00:00:02.480 --> 00:00:02.490 
at this time minoxidil is the only

00:00:02.490 --> 00:00:04.910 
at this time minoxidil is the only
treatment<00:00:02.730> approved<00:00:03.179> by<00:00:03.330> the<00:00:03.389> FDA<00:00:03.870> for<00:00:04.470> female

00:00:04.910 --> 00:00:04.920 
treatment approved by the FDA for female

00:00:04.920 --> 00:00:07.639 
treatment approved by the FDA for female
pattern<00:00:05.250> hair<00:00:05.609> loss<00:00:06.049> since<00:00:07.049> efficacy<00:00:07.529> is

00:00:07.639 --> 00:00:07.649 
pattern hair loss since efficacy is

00:00:07.649 --> 00:00:09.919 
pattern hair loss since efficacy is
marginal<00:00:08.160> at<00:00:08.250> best<00:00:08.280> a<00:00:08.820> lot<00:00:09.360> of<00:00:09.480> women<00:00:09.690> seek

00:00:09.919 --> 00:00:09.929 
marginal at best a lot of women seek

00:00:09.929 --> 00:00:12.020 
marginal at best a lot of women seek
alternative<00:00:10.650> treatments<00:00:11.070> to<00:00:11.429> help<00:00:11.460> regrow

00:00:12.020 --> 00:00:12.030 
alternative treatments to help regrow

00:00:12.030 --> 00:00:14.629 
alternative treatments to help regrow
their<00:00:12.300> hair<00:00:12.710> today<00:00:13.710> I'll<00:00:14.280> tell<00:00:14.460> you<00:00:14.549> about

00:00:14.629 --> 00:00:14.639 
their hair today I'll tell you about

00:00:14.639 --> 00:00:16.910 
their hair today I'll tell you about
vivir<00:00:14.969> scalp<00:00:15.299> a<00:00:15.480> new<00:00:15.780> dietary<00:00:16.350> supplement

00:00:16.910 --> 00:00:16.920 
vivir scalp a new dietary supplement

00:00:16.920 --> 00:00:18.710 
vivir scalp a new dietary supplement
containing<00:00:17.550> a<00:00:17.699> proprietary<00:00:18.270> blend<00:00:18.390> that

00:00:18.710 --> 00:00:18.720 
containing a proprietary blend that

00:00:18.720 --> 00:00:20.929 
containing a proprietary blend that
includes<00:00:19.020> marine<00:00:19.470> extracts<00:00:19.980> and<00:00:20.160> been<00:00:20.609> shown

00:00:20.929 --> 00:00:20.939 
includes marine extracts and been shown

00:00:20.939 --> 00:00:24.200 
includes marine extracts and been shown
to<00:00:21.180> have<00:00:21.270> encouraging<00:00:22.199> results<00:00:23.010> hello<00:00:23.760> i'm

00:00:24.200 --> 00:00:24.210 
to have encouraging results hello i'm

00:00:24.210 --> 00:00:31.280 
to have encouraging results hello i'm
dr.<00:00:24.990> neal<00:00:25.019> schultz<00:00:25.439> and<00:00:26.240> welcome

00:00:31.280 --> 00:00:31.290 

00:00:31.290 --> 00:00:34.340 

over<00:00:32.099> time<00:00:32.310> diffuse<00:00:33.180> hair<00:00:33.360> loss<00:00:33.540> in<00:00:33.750> women<00:00:33.780> can

00:00:34.340 --> 00:00:34.350 
over time diffuse hair loss in women can

00:00:34.350 --> 00:00:36.260 
over time diffuse hair loss in women can
progress<00:00:34.530> to<00:00:34.710> cosmetically<00:00:35.670> obvious

00:00:36.260 --> 00:00:36.270 
progress to cosmetically obvious

00:00:36.270 --> 00:00:39.290 
progress to cosmetically obvious
thinning<00:00:36.890> while<00:00:37.890> finasteride<00:00:38.340> also<00:00:39.000> known<00:00:39.180> as

00:00:39.290 --> 00:00:39.300 
thinning while finasteride also known as

00:00:39.300 --> 00:00:41.180 
thinning while finasteride also known as
propecia<00:00:39.660> has<00:00:40.170> been<00:00:40.410> shown<00:00:40.620> to<00:00:40.770> be<00:00:40.860> very

00:00:41.180 --> 00:00:41.190 
propecia has been shown to be very

00:00:41.190 --> 00:00:43.610 
propecia has been shown to be very
effective<00:00:41.640> in<00:00:41.940> regrowing<00:00:42.330> hair<00:00:42.480> in<00:00:42.750> men<00:00:42.930> its

00:00:43.610 --> 00:00:43.620 
effective in regrowing hair in men its

00:00:43.620 --> 00:00:46.130 
effective in regrowing hair in men its
use<00:00:43.860> in<00:00:44.100> postmenopausal<00:00:44.700> woman<00:00:45.210> has<00:00:45.720> not<00:00:45.930> been

00:00:46.130 --> 00:00:46.140 
use in postmenopausal woman has not been

00:00:46.140 --> 00:00:47.750 
use in postmenopausal woman has not been
effective<00:00:46.620> and<00:00:46.800> it<00:00:47.190> shouldn't<00:00:47.489> be<00:00:47.550> used

00:00:47.750 --> 00:00:47.760 
effective and it shouldn't be used

00:00:47.760 --> 00:00:50.510 
effective and it shouldn't be used
before<00:00:48.239> menopause<00:00:48.860> on<00:00:49.860> the<00:00:49.980> other<00:00:50.100> hand

00:00:50.510 --> 00:00:50.520 
before menopause on the other hand

00:00:50.520 --> 00:00:52.220 
before menopause on the other hand
Vivi's<00:00:51.090> cow<00:00:51.270> a<00:00:51.480> dietary<00:00:51.989> supplement

00:00:52.220 --> 00:00:52.230 
Vivi's cow a dietary supplement

00:00:52.230 --> 00:00:54.950 
Vivi's cow a dietary supplement
containing<00:00:52.949> a<00:00:53.210> proprietary<00:00:54.210> combination<00:00:54.480> of

00:00:54.950 --> 00:00:54.960 
containing a proprietary combination of

00:00:54.960 --> 00:00:57.049 
containing a proprietary combination of
marine<00:00:55.230> extracts<00:00:55.860> was<00:00:56.580> shown<00:00:56.790> to<00:00:56.940> be

00:00:57.049 --> 00:00:57.059 
marine extracts was shown to be

00:00:57.059 --> 00:00:58.670 
marine extracts was shown to be
moderately<00:00:57.600> helpful<00:00:58.050> in<00:00:58.230> a<00:00:58.320> placebo

00:00:58.670 --> 00:00:58.680 
moderately helpful in a placebo

00:00:58.680 --> 00:01:01.580 
moderately helpful in a placebo
controlled<00:00:59.190> study<00:00:59.280> involving<00:01:00.270> 15<00:01:00.780> women<00:01:01.140> with

00:01:01.580 --> 00:01:01.590 
controlled study involving 15 women with

00:01:01.590 --> 00:01:04.189 
controlled study involving 15 women with
self-perceived<00:01:02.520> hair<00:01:03.030> thinning<00:01:03.239> they<00:01:04.080> took

00:01:04.189 --> 00:01:04.199 
self-perceived hair thinning they took

00:01:04.199 --> 00:01:06.530 
self-perceived hair thinning they took
the<00:01:04.350> pill<00:01:04.530> for<00:01:04.710> 180<00:01:05.280> days<00:01:05.370> and<00:01:05.729> the<00:01:06.180> number<00:01:06.479> of

00:01:06.530 --> 00:01:06.540 
the pill for 180 days and the number of

00:01:06.540 --> 00:01:08.300 
the pill for 180 days and the number of
hairs<00:01:06.750> in<00:01:06.930> a<00:01:07.020> designated<00:01:07.590> area<00:01:07.800> of<00:01:08.010> the<00:01:08.100> scalp

00:01:08.300 --> 00:01:08.310 
hairs in a designated area of the scalp

00:01:08.310 --> 00:01:11.170 
hairs in a designated area of the scalp
were<00:01:08.729> counted<00:01:09.150> before<00:01:10.110> and<00:01:10.350> after<00:01:10.710> the<00:01:10.830> study

00:01:11.170 --> 00:01:11.180 
were counted before and after the study

00:01:11.180 --> 00:01:13.910 
were counted before and after the study
the<00:01:12.180> mean<00:01:12.420> number<00:01:12.600> of<00:01:12.750> mature<00:01:12.990> hairs<00:01:13.470> and<00:01:13.680> the

00:01:13.910 --> 00:01:13.920 
the mean number of mature hairs and the

00:01:13.920 --> 00:01:17.060 
the mean number of mature hairs and the
target<00:01:14.340> region<00:01:14.700> increased<00:01:15.390> from<00:01:15.740> 271<00:01:16.740> at<00:01:16.920> the

00:01:17.060 --> 00:01:17.070 
target region increased from 271 at the

00:01:17.070 --> 00:01:20.600 
target region increased from 271 at the
beginning<00:01:17.460> of<00:01:17.520> the<00:01:17.640> study<00:01:17.850> to<00:01:18.770> 571<00:01:19.770> at<00:01:20.070> 90<00:01:20.430> days

00:01:20.600 --> 00:01:20.610 
beginning of the study to 571 at 90 days

00:01:20.610 --> 00:01:23.539 
beginning of the study to 571 at 90 days
and<00:01:21.049> 610<00:01:22.049> at<00:01:22.260> a<00:01:22.530> hundred<00:01:22.950> and<00:01:23.100> eighty<00:01:23.280> days

00:01:23.539 --> 00:01:23.549 
and 610 at a hundred and eighty days

00:01:23.549 --> 00:01:26.539 
and 610 at a hundred and eighty days
these<00:01:24.479> results<00:01:24.990> were<00:01:25.350> significantly<00:01:26.130> higher

00:01:26.539 --> 00:01:26.549 
these results were significantly higher

00:01:26.549 --> 00:01:29.510 
these results were significantly higher
than<00:01:26.850> the<00:01:27.150> placebo<00:01:27.330> treated<00:01:28.229> group<00:01:28.460> for<00:01:29.460> the

00:01:29.510 --> 00:01:29.520 
than the placebo treated group for the

00:01:29.520 --> 00:01:31.940 
than the placebo treated group for the
stat<00:01:29.790> geeks<00:01:30.000> watching<00:01:30.540> the<00:01:30.900> p-value<00:01:31.560> was<00:01:31.710> less

00:01:31.940 --> 00:01:31.950 
stat geeks watching the p-value was less

00:01:31.950 --> 00:01:36.700 
stat geeks watching the p-value was less
than<00:01:32.659> 0.001<00:01:33.659> a<00:01:34.200> very<00:01:35.010> compelling<00:01:35.460> result

00:01:36.700 --> 00:01:36.710 
than 0.001 a very compelling result

00:01:36.710 --> 00:01:39.080 
than 0.001 a very compelling result
additionally<00:01:37.710> in<00:01:37.890> response<00:01:38.850> to<00:01:39.030> a

00:01:39.080 --> 00:01:39.090 
additionally in response to a

00:01:39.090 --> 00:01:41.210 
additionally in response to a
self-assessment<00:01:39.840> questionnaire<00:01:40.320> more

00:01:41.210 --> 00:01:41.220 
self-assessment questionnaire more

00:01:41.220 --> 00:01:43.340 
self-assessment questionnaire more
subjects<00:01:41.700> in<00:01:41.790> the<00:01:41.940> treated<00:01:42.300> group<00:01:42.420> reported

00:01:43.340 --> 00:01:43.350 
subjects in the treated group reported

00:01:43.350 --> 00:01:45.230 
subjects in the treated group reported
increased<00:01:43.830> hair<00:01:44.370> volume<00:01:44.790> than<00:01:45.030> in<00:01:45.150> the

00:01:45.230 --> 00:01:45.240 
increased hair volume than in the

00:01:45.240 --> 00:01:47.690 
increased hair volume than in the
placebo<00:01:45.600> group<00:01:45.780> and<00:01:46.340> there<00:01:47.340> were<00:01:47.430> no

00:01:47.690 --> 00:01:47.700 
placebo group and there were no

00:01:47.700 --> 00:01:50.600 
placebo group and there were no
side-effects<00:01:48.390> in<00:01:48.570> the<00:01:48.930> treated<00:01:49.260> group<00:01:49.610> the

00:01:50.600 --> 00:01:50.610 
side-effects in the treated group the

00:01:50.610 --> 00:01:52.490 
side-effects in the treated group the
bottom<00:01:50.910> line<00:01:51.120> is<00:01:51.300> that<00:01:51.420> this<00:01:51.720> study<00:01:51.990> supports

00:01:52.490 --> 00:01:52.500 
bottom line is that this study supports

00:01:52.500 --> 00:01:54.740 
bottom line is that this study supports
the<00:01:52.620> efficacy<00:01:53.160> and<00:01:53.340> tolerability<00:01:53.610> of<00:01:54.270> the

00:01:54.740 --> 00:01:54.750 
the efficacy and tolerability of the

00:01:54.750 --> 00:01:57.110 
the efficacy and tolerability of the
marine<00:01:55.020> extract<00:01:55.620> supplement<00:01:56.160> for<00:01:56.550> women<00:01:56.850> in

00:01:57.110 --> 00:01:57.120 
marine extract supplement for women in

00:01:57.120 --> 00:01:59.270 
marine extract supplement for women in
my<00:01:57.810> opinion<00:01:58.200> there's<00:01:58.650> very<00:01:58.950> little<00:01:59.160> known

00:01:59.270 --> 00:01:59.280 
my opinion there's very little known

00:01:59.280 --> 00:02:01.490 
my opinion there's very little known
downside<00:01:59.880> at<00:02:00.030> this<00:02:00.150> time<00:02:00.360> and<00:02:00.570> the<00:02:00.900> upside<00:02:01.320> is

00:02:01.490 --> 00:02:01.500 
downside at this time and the upside is

00:02:01.500 --> 00:02:02.380 
downside at this time and the upside is
promising

00:02:02.380 --> 00:02:02.390 
promising

00:02:02.390 --> 00:02:05.540 
promising
there's<00:02:03.390> Scala's<00:02:03.810> available<00:02:04.290> online<00:02:04.440> and<00:02:04.860> in

00:02:05.540 --> 00:02:05.550 
there's Scala's available online and in

00:02:05.550 --> 00:02:08.270 
there's Scala's available online and in
some<00:02:05.850> doctors<00:02:06.300> offices<00:02:06.870> please<00:02:07.860> join<00:02:08.099> me

00:02:08.270 --> 00:02:08.280 
some doctors offices please join me

00:02:08.280 --> 00:02:10.699 
some doctors offices please join me
again<00:02:08.310> at<00:02:08.729> dermtv.com<00:02:09.470> if<00:02:10.470> you<00:02:10.590> have<00:02:10.679> a

00:02:10.699 --> 00:02:10.709 
again at dermtv.com if you have a

00:02:10.709 --> 00:02:12.050 
again at dermtv.com if you have a
question<00:02:11.190> please<00:02:11.340> send<00:02:11.610> it<00:02:11.760> to<00:02:11.790> me<00:02:11.849> by

00:02:12.050 --> 00:02:12.060 
question please send it to me by

00:02:12.060 --> 00:02:15.350 
question please send it to me by
visiting<00:02:12.090> dermtv.com/question

00:02:15.350 --> 00:02:15.360 

00:02:15.360 --> 00:02:17.900 

I'm<00:02:15.810> dr.<00:02:16.200> Neal<00:02:16.410> Schultz<00:02:16.620> and<00:02:17.430> thank<00:02:17.460> you<00:02:17.760> for

00:02:17.900 --> 00:02:17.910 
I'm dr. Neal Schultz and thank you for

00:02:17.910 --> 00:02:20.480 
I'm dr. Neal Schultz and thank you for
watching<00:02:18.240> today

